Skip to content

Reconstruction of Complex Maxillary Defects using Patient-specific 3D-Printed Biodegradable Scaffolds

Craniofacial Reconstruction using a 3D printed Patient Specific Absorbable Mesh

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CRIS
Registry ID
KCT0002711
Enrollment
20
Registered
2018-02-28
Start date
2014-11-20
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery, Others(patient-specific 3D-printed biodepradable scaffolds) : A patient-specific polycaprolactone (PCL) scaffold was designed and fabricated for each patient. For this purpose, we u

Sponsors

The Catholic University of Korea, Seoul St. Mary's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The patients with complex orbital or maxillary defects after surgical removal of cancer or truma. Whom visited plastic and reconstuctive surgery department outpatient clinic and full informed consent was achived were enrolled in this study.

Exclusion criteria

Exclusion criteria: Exculsion criterias are 1. Age older than 60 (due to possible decreased regeneration capacity) 2. Pregnant woman or patients who are planning to get pregnant during the study. 3. Patients who has experienced severe adverse effect from any drug or history of severe allergic reactions. 4. Diabetes patients 5. Any patient who are under a medication for underlying diseases.

Design outcomes

Primary

MeasureTime frame
Regeneration of a deficient tissue while remaining stable in the body for a relatively long period of time

Secondary

MeasureTime frame
Improvement of facial contour

Countries

Korea, Republic of

Contacts

Public ContactJong-Won Rhie

The Catholic University of Korea, Seoul St. Mary's Hospital

rhiejw56@gmail.com+82-2-2258-6142

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026